Predictive Factors for Increased Bone Density Following Romosozumab Administration Based on Pre-Administration Blood Test Results
Romosozumab administration significantly increases bone density in osteoporosis, and assessing key predictive factors is necessary to ensure clinical effectiveness.
Authors
- Kohei Okuyama (ORCID: https://orcid.org/0000-0001-7312-5670)
- Seiji Ohtori (ORCID: https://orcid.org/0000-0001-5738-6184)
- Miyako Suzuki‐Narita (ORCID: https://orcid.org/0000-0001-6427-3807)
- Masahiro Inoue (ORCID: https://orcid.org/0000-0002-9518-9189)
- Noritaka Suzuki (ORCID: https://orcid.org/0000-0002-5009-1786)
- Atsushi Kuwabara (ORCID: https://orcid.org/0009-0004-9179-7525)
- Soichiro Tokeshi
- Sumihisa Orita (ORCID: https://orcid.org/0000-0003-2676-5469)
- Susumu Tashiro (ORCID: https://orcid.org/0009-0006-8126-1289)
- Noriyasu Toshi (ORCID: https://orcid.org/0000-0003-3424-7469)
- Kazuhide Inage (ORCID: https://orcid.org/0000-0003-0540-4613)
- Takahisa Hishiya (ORCID: https://orcid.org/0000-0001-7049-8615)
- Masaomi Yamashita (ORCID: https://orcid.org/0000-0002-6825-7182)
- Takahito Arai
- Yasuhiro Shiga (ORCID: https://orcid.org/0000-0003-4887-0008)
- Yawara Eguchi (ORCID: https://orcid.org/0000-0003-2247-5376)
- Shuhei Ohyama (ORCID: https://orcid.org/0000-0002-2947-4870)
Institutions
- Chiba University (JP)
- Funabashi Central Hospital (JP)
Publication Details
- Journal
- Yonsei Medical Journal
- Published
- 2024-12-24
- DOI
- https://doi.org/10.3349/ymj.2023.0535
- Citations
- 3
- Primary Topic
- Bone health and osteoporosis research
- Type
- article
- Field-Weighted Citation Impact
- 1.43